CLDN3 and neoplasm: (24) demonstrated that in a panel of non-squamous NSCLC cell lines (including H460, H1792, H157, H292, and A549), CLDN3 acts as a pro-tumorigenic factor under the regulation of estrogen receptor α (ERα), promoting tumor cell invasion.